Advertisement

Should We Tailor the Delineation of Pelvic Structures According to Tumor Presentation?

  • Maria Antonietta Gambacorta
  • Giuditta Chiloiro
  • Vincenzo Valentini
Chapter

Abstract

For decades, radiotherapy has played a fundamental role in promoting outcomes in rectal cancer. Preoperative administration of radiotherapy offers advantages compared to postoperative, and it is considered as the standard treatment in locally advanced rectal cancer [1]. Its role in improving local control still remains even after the introduction of total mesorectal excision (TME), as demonstrated in several randomized trials [2–5].

References

  1. 1.
    Sauer R1, Becker H, Hohenberger W, Rödel C et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740CrossRefPubMedGoogle Scholar
  2. 2.
    Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) Dutch colorectal cancer group the TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693–701CrossRefPubMedGoogle Scholar
  3. 3.
    Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomized trial. Lancet 373:811–820CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bosset JF, Collette L, Calais G et al (2007) Chemotherapy with preoperative radiotherapy in rectal cancer. New Engl J Med 355:1114–1123CrossRefGoogle Scholar
  5. 5.
    Gerard JP, Conroy T, Bonnetain F et al (2006) Radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620–4625CrossRefPubMedGoogle Scholar
  6. 6.
    Gunderson LL, Russell AH, Llewellyn HJ et al (1985) Treatment planning for colorectal cancer: radiation and surgical techniques and value of small-bowel films. Int J Radiat Oncol Biol Phys 11:1379–1393CrossRefPubMedGoogle Scholar
  7. 7.
    Widder J, Sedlmayer F, Stanek C, Potter R (2000) Quality assurance in preoperative radiotherapy of rectal cancer: evaluation of pre-trial dummy-run. Radiother Oncol 56:341–347CrossRefPubMedGoogle Scholar
  8. 8.
    Nijkamp J, de Haas-Kock DFM (2012) Beukema, et al. target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands. Radiother Oncol 102(1):14–21CrossRefPubMedGoogle Scholar
  9. 9.
    Fuller CD, Nijkamp J, Duppen JC et al (2010) Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. Int J Radiat Oncol Biol Phys 79:481–489CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ng M, Leong T, Chander S et al (2012) Australasian gastrointestinal trials group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys 83(5):1455–1462CrossRefPubMedGoogle Scholar
  11. 11.
    Roels S, Duthoy W, Haustermans K et al (2006) Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 65:1129–1142CrossRefPubMedGoogle Scholar
  12. 12.
    Myerson RJ, Garofalo MC, El Naqa I et al (2009) Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74:824–830CrossRefPubMedGoogle Scholar
  13. 13.
    Arcangeli S, Valentini V, Nori SL et al (2003) Underlying anatomy for CTV contouring and lymphatic drainage in rectal cancer radiation therapy. Rays 28(3):331–336PubMedGoogle Scholar
  14. 14.
    Langelé BG (2003) Clinical target volume in conformal and intensity modulated radiation therapy. A clinical guide to cancer treatment. In: Grégoire V, Scalliet P, Ang KK (eds) The lymphatic system, 1st edn. Springer, Heidelberg, pp 23–31Google Scholar
  15. 15.
    Kusters M, Marijnen CAM, van de Velde CJH (2010) Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 36:470–476CrossRefPubMedGoogle Scholar
  16. 16.
    Kusters M, Wallner C, Lange MM et al (2010) Origin of presacral recurrence after rectal cancer treatment. Br J Surg 97:1582–1588CrossRefPubMedGoogle Scholar
  17. 17.
    Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery – the clue for pelvic recurrence? Br J Surg 69:613–616CrossRefPubMedGoogle Scholar
  18. 18.
    Syk E, Torkzad MR, Blomqvist L et al (2008) Local recurrence in rectal cancer: anatomic localization and effect on radiation target. Int J Radiat Oncol Biol Phys 72:658–664CrossRefPubMedGoogle Scholar
  19. 19.
    Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26:303–312CrossRefPubMedGoogle Scholar
  20. 20.
    Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93(10):1215–1223CrossRefPubMedGoogle Scholar
  21. 21.
    MERCURY Study GroupDiagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer, prospective observational study. BMJ 333(7272):779Google Scholar
  22. 22.
    Hruby G, Barton M, Miles S et al (2003) Sites of local recurrence after surgery, with or without chemotherapy, for rectal cancer: implications for radiotherapy field design. Int J Radiat Oncol Biol Phys 55:138–143CrossRefPubMedGoogle Scholar
  23. 23.
    Nijkamp J, Kusters M, Beets-Tan R et al (2011) Three-dimensional analysis of recurrences patterns in rectal cancer: the cranial border in the hypofractionated preoperative radiotherapy can be lowered. Int J Radiat Oncol Biol Phys 80(1):103–110CrossRefPubMedGoogle Scholar
  24. 24.
    Sato H, Maeda K, Maruta M et al (2006) Who can get the beneficial effect from lateral lymph node dissection for Dukes C rectal carcinoma below the peritoneal reflection? Dis Colon Rectum 49(10 Suppl):S3–12CrossRefPubMedGoogle Scholar
  25. 25.
    Koda K, Saito N, Oda K, Takiguchi N et al (2004) Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle to lower rectal cancers. Int J Color Dis 19:188–194CrossRefGoogle Scholar
  26. 26.
    Ueno H, Mochizuki H, Hashiguchi Y et al (2007) Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection. Ann Surg 245:80–87CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Ueno M, Oya M, Azekura K et al (2005) Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 92:756–763CrossRefPubMedGoogle Scholar
  28. 28.
    Kim TH, Jeong SY, Choi DH et al (2008) Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 15:729–737CrossRefPubMedGoogle Scholar
  29. 29.
    Kusters M, van de Velde CJ, Beets-Tan RG et al (2008) Patterns of local recurrence in rectal cancer: a single-center experience. Ann Surg Oncol 16:289–296CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Kusters M, Beets GL, van de Velde CJ et al (2009) A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg 249:229–235CrossRefPubMedGoogle Scholar
  31. 31.
    Nagawa H, Muto T, Sunouchi K et al (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44:1274–1280CrossRefPubMedGoogle Scholar
  32. 32.
    Yu TK, Bhosale PR, Crane CH et al (2008) Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 71:1175–1180CrossRefPubMedGoogle Scholar
  33. 33.
    Mangan CE, Rubin SC, Ds R et al (1986) Lymphnode nomenclature in the gynecologic oncology. Gynecol Oncol 23:222–226CrossRefPubMedGoogle Scholar
  34. 34.
    Steup WH, Moriya Y, van de Velde CJH (2002) Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer 38:911–918CrossRefPubMedGoogle Scholar
  35. 35.
    Koh DM, Chau I, Tait D et al (2008) Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant. Int J Radiat Oncol Biol Phys 71:456–461CrossRefPubMedGoogle Scholar
  36. 36.
    Bujko K, Bujko M, Pietrzak L (2007) Clinical target volume for rectal cancer: in regard to Roels et al. (Int J Radiat Oncol Biol Phys 2006;65:1129–1142). Int J Radiat Oncol Biol Phys 68:313CrossRefPubMedGoogle Scholar
  37. 37.
    Joye I, Haustermans K (2015) Clinical target volume delineation for rectal cancer radiation therapy: time for updated guidelines? Int J Radiat Oncol Biol Phys 91(4):690–691CrossRefPubMedGoogle Scholar
  38. 38.
    Taylor A, Rockall AG, Powell ME (2007) An atlas of the pelvic lymph node regions to aid radio- therapy target volume definition. Clin Oncol (R Coll Radiol) 19:542–550CrossRefGoogle Scholar
  39. 39.
    Ippolito E, Mertens I, Haustermans K et al (2008) IGRT in rectal cancer. Acta Oncol 47:1317–1324CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2018

Authors and Affiliations

  • Maria Antonietta Gambacorta
    • 1
  • Giuditta Chiloiro
    • 1
  • Vincenzo Valentini
    • 1
  1. 1.Department of Radiotherapy-Gemelli ARTFondazione Policlinico Universitario A. GemelliRomeItaly

Personalised recommendations